
AJUNTAMENT D'ALCOI
Website

Generalitat Valenciana
Website

Ayuntamiento de Valencia
Website

Cicloplast
Website

Ayuntamiento de Onil
Website

Anarpla
Website

Ayuntamiento de Mislata
Website

nlWA, North London Waste Authority
Website

Ayuntamiento de Salinas
Website

Zicla
Website

Fondazione Ecosistemi
Website

PEFC
Website

ALQUIENVAS
Website

DIPUTACI� DE VAL�NCIA
Website

AYUNTAMIENTO DE REQUENA
Website

UNIVERSIDAD DE ZARAGOZA
Website

OBSERVATORIO CONTRATACIÓN PÚBLICA
Website

AYUNTAMIENTO DE PAIPORTA
Website

AYUNTAMIENTO DE CUENCA
Website

BERL� S.A.
Website

CM PLASTIK
Website

TRANSFORMADORES INDUSTRIALES ECOL�GICOS

INDUSTRIAS AGAPITO
Website

RUBI KANGURO
Website
If you want to support our LIFE project as a STAKEHOLDER, please contact with us: life-future-project@aimplas.es
In this section, you can access to the latest technical information related to the FUTURE project topic.
Polygala tenuifolia-Acori tatarinowii herbal pair as an inspiration for substituted cinnamic ?-asaronol esters: Design, synthesis, anticonvulsant activity, and inhibition of lactate dehydrogenase study
Inspired by the traditional Chinese herbal pair of Polygala tenuifolia-Acori Tatarinowii for treating epilepsy, 33 novel substituted cinnamic ?-asaronol esters and analogues were designed by Combination of Traditional Chinese Medicine Molecular Chemistry (CTCMMC) strategy, synthesized and tested systematically not only for anticonvulsant activity in three mouse models but also for LDH inhibitory activity. Thereinto, 68?70 and 75 displayed excellent and broad spectra of anticonvulsant activities with modest ability in preventing neuropathic pain, as well as low neurotoxicity. The protective indices of these four compounds compared favorably with stiripentol, lacosamide, carbamazepine and valproic acid. 68?70 exhibited good LDH1 and LDH5 inhibitory activities with noncompetitive inhibition type, and were more potent than stiripentol. Notably, 70, as a representative agent, was also shown as a moderately positive allosteric modulator at human ?1?2?2 GABAA receptors (EC50 46.3???7.3??M). Thus, 68?70 were promising candidates for developing into anti-epileptic drugs, especially for treatment of refractory epilepsies such as Dravet syndrome.
Graphical abstractChart 1. Compounds with subunit of propenylic phenylpropene.

» Author: Yajun Bai, Xirui He, Yujun Bai, Ying Sun, Zefeng Zhao, Xufei Chen, Bin Li, Jing Xie, Yang Li, Pu Jia, Xue Meng, Ye Zhao, Yanrui Ding, Chaoni Xiao, Shixiang Wang, Jie Yu, Sha Liao, Yajun Zhang, Zhiling Zhu, Qiang Zhang
» Publication Date: 01/12/2019
C/ Gustave Eiffel, 4
(València Parc Tecnològic) - 46980
PATERNA (Valencia) - SPAIN
(+34) 96 136 60 40
Project Management department - Sustainability and Industrial Recovery
life-future-project@aimplas.es
